Lubin Investment · Analyze · Screener · Compare

Best Biotechnology stocks by quality

Of the 60 stocks listed here, 6 reach the maximum quality score. The median valuation of the group comes out at 16.5 times its free cash flow. Among those with the maximum score, the cheapest is Philogen (PHIL.MI), at 3.7 times its free cash flow.

The Biotechnology stocks with the highest scores from our fundamental analysis, ranked from best to worst quality, with their valuation (P/FCF). Click a stock for its full analysis.

#StockQuality scoreP/FCF
1UCB SA (UCB.BR)10/1023.5x
2Philogen S.p.A. (PHIL.MI)10/103.7x
3Jazz Pharmaceuticals PLC (JAZZ)10/1017.1x
4Exelixis Inc (EXEL)10/1016.5x
5Anthem Biosciences Limited (ANTHEM.NS)10/1083.7x
63SBio Inc. (1530.HK)10/104.3x
7Theravance Biopharma Inc (TBPH)9/103.5x
8Pharming Group N.V. (PHARM.AS)9/1012.6x
9Krystal Biotech Inc (KRYS)9/1052.9x
10Harmony Biosciences Holdings Inc (HRMY)9/107.5x
11Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (688796.SS)9/10162.9x
12Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)9/1017.4x
13Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)9/1012.3x
14Medtide Inc. (3880.HK)9/1017.5x
15SK Biopharmaceuticals Co., Ltd. (326030.KS)9/1041.7x
16Qyuns Therapeutics Co., Ltd. (2509.HK)9/108.2x
17Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)9/1089.6x
18Heartseed Inc. (219A.T)9/1042.7x
19Pharmicell Co., Ltd. (005690.KS)9/1020.1x
20Zealand Pharma A/S (ZEAL.CO)8/103.3x
21WuXi Biologics (Cayman) Inc. (WUXI13.BK)8/101.0x
22Vytrus Biotech, S.A. (VYT.MC)8/1094.9x
23Vericel Corp (VCEL)8/1094.8x
24Sino Biopharmaceutical Limited (SINOBIO19.BK)8/102.2x
25Rigel Pharmaceuticals Inc (RIGL)8/1011.5x
26Pharma Mar, S.A. (PHM.MC)8/1032.3x
27Pharming Group NV (PHAR)8/1014.7x
28Incyte Corp (INCY)8/1014.1x
29Halozyme Therapeutics Inc (HALO)8/1020.0x
30Genmab A/S (GMAB.CO)8/10110.8x
31Clinuvel Pharmaceuticals Ltd (CUVL)8/105.2x
32Catalyst Pharmaceuticals Inc (CPRX)8/1021.1x
33Basilea Pharmaceutica AG (BSLN.SW)8/1015.3x
34Bavarian Nordic A/S (BAVA.CO)8/1010.5x
35Aurinia Pharmaceuticals Inc (AUPH)8/1013.3x
36Plant Advanced Technologies SA (ALPAT.PA)8/102.6x
37Xiamen Amoytop Biotech Co., Ltd. (688278.SS)8/1049.3x
38Shanghai Model Organisms Center, Inc. (688265.SS)8/1088.9x
39BeOne Medicines AG (688235.SS)8/1063.8x
40BeOne Medicines AG (6160.HK)8/1047.7x
41Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (2566.HK)8/106.2x
42WuXi Biologics (Cayman) Inc. (2269.HK)8/1052.5x
43HBM Holdings Limited (2142.HK)8/1020.0x
44Innovent Biologics, Inc. (1801.HK)8/1015.3x
45Sinphar Pharmaceutical Co.,Ltd. (1734.TW)8/1017.5x
46Sino Biopharmaceutical Limited (1177.HK)8/1011.1x
47Supriya Lifescience Limited (SUPRIYA.NS)7/10217.1x
48Septerna Inc (SEPN)7/1018.3x
49Royalty Pharma PLC (RPRX)7/1012.5x
50Pulmatrix Inc (PULM)7/10n.d.
51Puma Biotechnology Inc (PBYI)7/109.8x
52Omeros Corp (OMER)7/10n.d.
53MacroGenics Inc (MGNX)7/10n.d.
54MiMedx Group Inc (MDXG)7/1016.2x
55Lite Strategy Inc (LITS)7/10n.d.
56Inter Pharma Public Company Limited (IP.BK)7/1018.2x
57GeoVax Labs Inc (GOVX)7/10n.d.
58EZZ Life Science Holdings Limited (EZZ.AX)7/105.4x
59Dimerix Limited (DXB.AX)7/103.9x
60Clinuvel Pharmaceuticals Limited (CUV.AX)7/1011.7x

Our quality score judges how solid a business is across 10 objective financial criteria (profitability, free cash flow growth, share buybacks, debt, return on capital). The P/FCF (price to free cash flow) shows whether the stock is cheap or expensive. Full method: our methodology.

To place these multiples against sector averages, the reference public sector data is Aswath Damodaran's (NYU Stern).

Explore the full screener